The Library of Congress > Linked Data Service > BIBFRAME Works

Bibframe Work

Title
Clinical dilemmas in non-alcoholic fatty liver disease
Type
Text
Monograph
Subject
Non-alcoholic Fatty Liver Disease (MESH)
Language
English
Illustrative Content
Illustrations
Classification
LCC: RC848.F3 C55 2016 (Assigner: dlc) (Status: not used by assigner)
NLM: WI 700 (Assigner: dnlm) (Status: not used by assigner)
DDC: 616.3/62 full (Assigner: dlc)(Source: 23)
Supplementary Content
bibliography
index
Content
text
Table Of Contents
Hype or harm from fatty liver disease? / Stephen H Caldwell and Curt Argo
Worldwide problem / Geoffrey Farrell and Philip Newsome
Is insulin resistance the key motive for NAFLD? / Desmond Johnston
Progression to cirrhosis is more likely in children with NAFLD? / Anil Dhawan
NAFLD as cause of cryptogenic cirrhosis? / Jay Lefkowitch
Is NAFLD different in absence of metabolic syndrome? / Yusuf Yilmaz
Occurrence of noncirrhotic HCC in NAFLD / Stephen Harrison and Dawn Torres
Fibrosis progression molecular pathways all important? / Anna-Mae Diehl and Dr Wing-Kin Syn
Can fatty liver of NAFLD be distinguished from that of alcoholic liver disease? / David Kleiner and Elizabeth Brunt
Are inflammasomes and intestinal microbiota relevant in disease progression to NASH? / M. Bilal Siddiqui, M. Shadab Siddiqui and Arun Sanyal
Can genetic influence in non-alcoholic fatty liver disease be ignored? / Quentin Anstee
Is there a mechanistic link between hepatic steatosis and cardiac rather than liver events? / Soo Lim
Is there a best method for diagnosis of NAFLD? / Vlad Ratziu
Choice of non-invasive blood tests and FibroScan / Massimo Pinzani and Manolis Tsocatzis
Are the guidelines AASLD, IASL, EASL and BSG of help? / Jean-Francois Dufour
How to choose from different imaging modalities and screening techniques / Hero Hussain
Are the pros outweighed by the cons of obtaining a liver biopsy? / Simon Taylor-Robinson and Jeremy Cobbold
Screening for NAFLD in high risk population / Nader Lessan
Balancing calorie restriction, exercise and weight reduction / Nicholas Finer
Should physicians be prescribing, or patients self-medicating with Orlistat, vitamin E, vitamin D, insulin antagonist, Trental and coffee? / Brent Neuschwander-Tetri and Haripriya Maddur
Does improvement in hepatic steatosis have a significant favourable effect on the metabolic syndrome, including diabetes? / Jukka Westerbacka
What are the dangers as well as the true benefits of bariatric surgery? / Andrew Jenkinson
Liver transplantation : what can it offer? / Roger Williams
Molecular antagonists, leptin or other hormones in supplementing environmental factors? / Jeremy Tomlinson
Use of antifibrotic agents in clinical practice / Jonathan Fallowfield
Better understanding of early development and material influence? / Jude Oben
Defining the role of metabolic physician / Nicholas Finer.
Authorized Access Point
Clinical dilemmas in non-alcoholic fatty liver disease